Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02848274

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.

Conditions

Timeline

Start date
2016-10-01
Primary completion
2027-03-01
Completion
2027-03-01
First posted
2016-07-28
Last updated
2025-10-22

Locations

13 sites across 7 countries: United States, Argentina, Australia, Brazil, China, Japan, United Kingdom

Source: ClinicalTrials.gov record NCT02848274. Inclusion in this directory is not an endorsement.

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome (NCT02848274) · Clinical Trials Directory